| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |